Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Advanced Thyroid Cancer
NCT01964144Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jan 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in thyroid cancer, sponsored by Yonsei University. Started Jan 2013; status: completed.
02
Drugs
dovitinib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT01964144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964144.